Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
Title:
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
Author:
Liu, Xinxue Shaw, Robert H Stuart, Arabella S V Greenland, Melanie Aley, Parvinder K Andrews, Nick J Cameron, J Claire Charlton, Sue Clutterbuck, Elizabeth A Collins, Andrea M Dinesh, Tanya England, Anna Faust, Saul N Ferreira, Daniela M Finn, Adam Green, Christopher A Hallis, Bassam Heath, Paul T Hill, Helen Lambe, Teresa Lazarus, Rajeka Libri, Vincenzo Long, Fei Mujadidi, Yama F Plested, Emma L Provstgaard-Morys, Samuel Ramasamy, Maheshi N Ramsay, Mary Read, Robert C Robinson, Hannah Singh, Nisha Turner, David P J Turner, Paul J Walker, Laura L White, Rachel Nguyen-Van-Tam, Jonathan S Snape, Matthew D